B. Riley Financial, Inc. Rigel Pharmaceuticals Inc Transaction History

B. Riley Financial, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$2.08 - $3.36 $984,553 - $1.59 Million	-473,343 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$2.6 - $3.59 $385,691 - $532,551	148,343 Added 45.64%	473,343 $1.52 Million
Q2 2018 Aug 14, 2018	BUY	$2.83 - $4.11 $919,750 - $1.34 Million	325,000 New	325,000 $920,000
Q1 2018 May 04, 2018	SELL	$3.54 - $4.54 $624,810 - $801,310	-176,500 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$3.23 - $4.3 $98,515 - $131,150	-30,500 Reduced 14.73%	176,500 $685,000
Q3 2017 Nov 13, 2017	BUY	$2.18 - $2.57 $451,260 - $531,990	207,000	207,000 $526,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $4.17B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of B. Riley Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on B. Riley Financial, Inc. with notifications on news.